MICHAEL PRING: Open Payments
NPI 1760075451 · LIVINGSTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$151 in 8 payments from 5 companies in 2025. Trend: 2023 $223 · 2024 $52 · 2025 $151
Food & beverage: $151
| Company | Payments | Amount |
|---|---|---|
| Shionogi Inc | 2 | $39 |
| Aimmune Therapeutics, Inc. | 2 | $38 |
| ABBVIE INC. | 2 | $34 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| Insmed, Inc. | 1 | $18 |
Products named: Fetroja, VOWST, PIFELTRO, EMBLAVEO, Arikayce, AVYCAZ.
Industry payments across NJ — which companies pay providers there.
